terrain trial of enzalutamide versus bicalutamide for advanced prostate cancer
Published 8 years ago • 598 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:30
terrain: enzalutamide versus bicalutamide for metastatic prostate cancer
-
1:55
arches trial overview: adt plus enzalutamide for metastatic hormone-sensitive prostate cancer
-
2:38
dr. karsh on the terrain trial for prostate cancer
-
4:12
ocuu-crpc trial: enzalutamide vs. flutamide for crpc after bicalutamide
-
5:16
enzamet: enzalutamide for metastatic prostate cancer
-
5:14
olaparib and keytruda for advanced prostate cancer | | learn about clinical trials
-
0:53
embark: subset analysis of enzalutamide versus leuprolide in prostate cancer
-
1:52
clinical trial of enzamet shows it promising as prostate cancer treatment
-
6:40
updated overall survival outcomes in enzamet (anzup 1304)
-
1:03
dr. zhang on the arches trial in prostate cancer
-
1:59
enzalutamide (mdv3100): key drug for advanced prostate cancer treatment | glpbio
-
2:17
enzalutamide for biochemically recurrent prostate cancer | nejm
-
3:26
scandinavian prostate cancer group (spcg) trial 14
-
4:57
asco gu 2018: enzalutamide vs. bicalutamide for metastatic hormone sensitive prostate cancer
-
2:13
head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic crpc
-
1:34
dr. chi on abiraterone versus enzalutamide for metastatic castration-resistant prostate cancer
-
2:50
prosper: enzalutamide vs. placebo for nmcrpc
-
2:45
trial of lhrha, abiraterone and enzalutamide: filling an unmet need in prostate cancer therapy
-
1:20
dr. shore on the terrain trial for prostate cancer